Masimo Corporation
Irvine, California, 92618, United States
NCT Number: NCT05332392
This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation and pulse rate to reference values obtained by a laboratory blood gas analyzer and a standard of care EKG monitor.
Study procedures follow ISO-80601-2-61:2011 standard requirements for basic safety and essential performance of pulse oximeter equipment. Arterial blood samples will be collected from subjects while undergoing a controlled desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced until the subject's arterial oxygen concentration is approximately 70%.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Irvine, California, 92618, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Noninvasive wearable health monitoring device
Time frame: 1-5 hours
SpO2 performance will be determined by calculating the arithmetic root square mean (ARMS) value through the comparison of the noninvasive SpO2 measurement obtained from INVSENSOR00040 to the arterial oxygen saturation (SaO2) value obtained from a reference blood sample.
The square root of the sum of the squares of bias and precision is computed as the ARMS Error Value.
The desaturation range over which the accuracy is performed is 70-100%.
Time frame: 1-5 hours
Pulse Rate (PR) performance will be determined by calculating the ARMS value through the comparison of the PR values obtained from INVSENSOR00040 to the heart rate (HR) values obtained from a reference standard of care EKG monitor.
The square root of the sum of the squares of bias and precision is computed as the ARMS Error Value.
The PR/HR range over which the accuracy is calculated is determined by convenience sampling in a generally healthy population undergoing a desaturation procedure.
Masimo Corporation
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details